Core Viewpoint - The performance briefing held by Xi'an International Medical Investment Co., Ltd. on August 22, 2025, highlighted the company's operational developments and financial performance for the first half of 2025, with a focus on service expansion, cost control, and strategic adjustments in response to market conditions [1]. Group 1: Operational Developments - In the first half of 2025, the company established one provincial-level clinical key specialty project and completed 636 clinical application filings for restricted technologies, along with obtaining 24 national patents and initiating 13 clinical trial projects for drugs and medical devices, indicating an expansion in academic influence [2]. - The company launched a high-end specialty service in the newly established International Medical Center Hospital and opened a 100-bed elderly care facility to address aging population needs [2]. - The company enhanced patient service experiences and smart healthcare capabilities, optimizing the entire patient service process and expanding internet hospital services [2]. Group 2: Financial Performance - In the first half of 2025, the total outpatient and emergency service volume reached 1.3191 million visits, a year-on-year increase of 5.42%, while inpatient service volume decreased by 4.01% to 96,300 visits [3]. - The company reported operating revenue of 2.0343 billion yuan, a year-on-year decrease of 15.95%, and a net profit attributable to shareholders of -164.96 million yuan, a reduction in losses by 4.98% [3]. - Operating cash flow net amount was 592.54 million yuan, an increase of 12.75% compared to the same period last year [3]. Group 3: Specific Hospital Performance - Xi'an Gaoxin Hospital recorded an outpatient and emergency service volume of 578,700 visits, with operating revenue of 638.74 million yuan, a year-on-year decrease of 17.30%, and a net profit of 30.98 million yuan, down 37.48% [4]. - Xi'an International Medical Center Hospital had an outpatient and emergency service volume of 740,500 visits, a year-on-year increase of 7.37%, but inpatient service volume decreased by 2.80% to 66,000 visits, with operating revenue of 1.3833 billion yuan, down 15.37%, and a net profit of -113.21 million yuan, a decrease of 44.63% [4]. - The company implemented cost control measures, including bed integration and department optimization, and saw an increase in the proportion of out-of-town patients, reaching 35% for Xi'an Gaoxin Hospital and 42% for Xi'an International Medical Center Hospital [4].
调研速递|西安国际医学接受天风证券等17家机构调研 上半年业绩关键数据披露